Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway.
复制标题
DOI：
10.1016/j.neo.2015.04.002
复制
发表时间：
2015-05
期刊：
影响因子：
4.8
通讯作者：
Gu, Yanhong
中科院分区：
文献类型：
--
作者：
Yuan, Huaqin;Meng, Xiaoxin;Guo, Wenjie;Cai, Peifen;Li, Wanshuai;Li, Qian;Wang, Weicheng;Sun, Yang;Xu, Qiang;Gu, Yanhong
Intrarenal interleukin-15 (IL-15) plays a major role controlling epithelial survival and polarization both in physiological and pathologic conditions. Herein, we confirmed that human renal cell carcinomas (RCCs) express a membrane-bound IL-15 isoform displaying an unusual molecular weight of 27 kDa. Its stimulation with soluble IL-15 receptor α chain (s-IL-15Rα) triggers epithelial-mesenchymal transition (EMT) process as shown by the down-regulation of E-cadherin and zona occludens 1 and the up-regulation of vimentin and N-cadherin and promotes the migratory and invasive properties of RCC. S-IL-15Rα treatment triggered the Src/PI3K/Akt/GSK-3β pathway and promoted β-catenin nuclei translocation. Deactivation of this pathway by using Src-specific inhibitor PP2, PI3K inhibitor LY294002, and AKT inhibitor MK2206 hampered β-catenin nuclei translocation and suppressed EMT, migration, and invasion of RCC. S-IL-15Rα treatment also enhanced Src-dependent phosphorylation of focal adhesion kinase (FAK) and extracellular signal–regulated kinase (Erk1/2). FAK knockdown significantly decreased the migration and invasion of RCC, which suggest that Src-FAK signaling was involved in s-IL-15Rα–favored migration and invasion of RCC. At the same time, inhibitors of Erk1/2 also significantly decreased the migration and invasion of RCC but could not reverse s-IL-15Rα–induced EMT. Taken together, our results reveal that Src-dependent PI3K/Akt/GSK3b/β-catenin pathway is required for s-IL-15Ra–dependent induction of EMT in RCC, while Src-FAK and Src-Erk1/2 signaling were involved in s-IL-15Rα–promoted migration and invasion properties of RCC. Our study provides a better understanding of IL-15 signaling in RCC tumor progression, which may lead to novel targeted therapies and provide some suggestions when using IL-15 in clinic.
登录
查看更多内容
影响因子：
5.7
作者：
Golubovskaya VM;Huang G;Ho B;Yemma M;Morrison CD;Lee J;Eliceiri BP;Cance WG
通讯作者：
Cance WG
影响因子：
2.7
作者：
Sampath D;Malik A;Plunkett W;Nowak B;Williams B;Burton M;Verstovsek S;Faderl S;Garcia-Manero G;List AF;Sebti S;Kantarjian HM;Ravandi F;Lancet JE
通讯作者：
Lancet JE
电子 - 钙黏着蛋白的阴暗面：可能在肿瘤进展中的作用。
影响因子：
11.2
作者：
Rodriguez, Fausto J.;Lewis-Tuffin, Laura J.;Anastasiadis, Panos Z.
通讯作者：
Anastasiadis, Panos Z.
影响因子：
4.8
作者：
Budagian, V;Bulanova, E;Bulfone-Paus, S
通讯作者：
Bulfone-Paus, S
影响因子：
9.7
作者：
Macha, Muzafar A.;Rachagani, Satyanarayana;Gupta, Suprit;Pai, Priya;Ponnusamy, Moorthy P.;Batra, Surinder K.;Jain, Maneesh
通讯作者：
Jain, Maneesh